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Abstract
Background: Histologically documented cases of parvoviral myocarditis are exceedingly rare.
Case presentation: Here, we report a 41-year old African American immunocompetent patient
who died of parvoviral myocarditis after a 10 day illness characterized by fever, headaches,
generalized arthralgias, and a maculopapular rash.
Autopsy revealed an infiltrate myocarditis composed primarily of T-lymphocytes and macrophages
associated with extensive myocardial fibrosis. The diagnosis of parvovirus was determined by
polymerase chain reaction (PCR) on both pre-mortem serum and post-mortem myocardial tissue
Methods:  DNA was extracted from tissue and serum and primers were used to amplify
DNAsequences of parvovirus B19 using nested polymerase chain reaction (PCR).
Conclusion: The diagnosis of parvovirus should be considered in cases of fatal myocarditis, and
diagnosis can be confirmed at autopsy by molecular techniques.
Introduction
Parvovirus B19 (PB19) was discovered in 1974 and is the
only member of the family Parvoviridae known to be path-
ogenic in humans[1]. It is endemic in humans worldwide,
as antiparvovirus IgG antibody is present in asymptomatic
patients in the United States, Europe, and Asia[2]. Infec-
tion is generally self-limited and in children typically
presents as erythema infectiosum. Other manifestations
of parvovirus infection include hydrops fetalis, arthropa-
thy, and acute hepatitis [3-6]. In immunocompromised
patients, PB19 infection of erythropoetic cells may result
in anemia, and occasionally acute lung infections[7].
The most common etiologies are infectious agents, hyper-
sensitivity responses, or immune-related injury[8]. How-
ever, the etiology might go unrecognized secondary to
difficulties in identifying infectious agents. This is particu-
larly truth for viruses in the early stage of infection before
the virus is cleared by the immune system. The detection
of viral genomes in endomyocardial biopsies by molecu-
lar techniques, especially PCR, has greatly expanded the
list of viruses implicated in myocarditis. Initially, the
molecular diagnosis of the viral etiology of myocarditis
focused on the enteroviruses. More recently, parvovirus
has been detected in a small proportion of heart tissues in
patients with histologically documented myocarditis [9-
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11], although the importance of parvovirus in the patho-
genesis of myocarditis, especially in adults, remains
unclear.
The purpose of this report is to illustrate a rare case of
serologically proven parvovirus myocarditis in which the
diagnosis was confirmed by molecular techniques. In
addition, the histologic features and immunophenotyp-
ing of the inflammatory infiltrates are presented.
Case presentation
A 41-year-old African-American man with a history of
hypertension presented to a health clinic with a one
month history fevers, chills, mild dyspnea, generalized
althralgias, and a maculopapular rash, he was treated with
levofloxacin and discharged. However, five days later the
patient was admitted to the emergency department with a
fever of over 40°C. During the course of three days the
patient had episodes of marked dyspnea, with up to forty-
four breaths per minute, as well as a blood pressure of 80/
50, he was intubated, placed on pressors and transferred
to our institution. Further workup revealed diffuse intra-
vascular coagulation (DIC) with D-dimer > 5000 and
multiorgan failure including fulminant hepatic failure
(AST 12,300 U/L, ALT 4,900), acute renal failure (BUN 52
and creatinine of 5.2), and cardio-respiratory failure. Elec-
trocardiograms demonstrated atrial fibrillation with right
bundle branch block and diffuse low voltage. A chest radi-
ograph showed cardiomegaly and acute respiratory dis-
tress syndrome. A transthoracic echocardiogram was
performed demonstrating biventricular dilatation, global
hypokinesis, and right and left ejection fractions of 20%
and 17%, respectively.
Serology for IgG toxoplasmosis Ab, cytomegalovirus IgM
and serum DNA PCR for Parvovirus was positive. Serology
was negative for human immunodeficiency virus, Epstein
Barr virus, West Nile virus, viral hepatitis, Streptococcus,
Influenza, Rickettsia, Coxackie, Legionella, and Adenovi-
rus, as well as PCR for Enterovirus, Ehrlichia, and Lyme.
The patient's CD4 count was 341/ml with negative blood
cultures through the hospital course, a tracheal culture
taken hours before death grew Candida sp, presumably
due to prolonged intubation. Despite aggressive medical
support, he expired 7 days after admission.
Methods
DNA was extracted from tissue and serum and primers
were used to amplify DNA sequences of parvovirus B19
using nested polymerase chain reaction (PCR). The PCR
products were separated by electrophoresis on 2% agarose
gel and placed under UV light for visualization the ampli-
fied products.
DNA was extracted from tissue (Qiagen® DNA kit). Four
sets of primers were used to amplify DNA sequences of
parvovirus B19 using nested polymerase chain reaction
(PCR). PCR contained 4 different concentrations of DNA
sample, 140 nmol of each primer, 200 µmol of dNTPs, 2.5
units of HotStart Taq DNA polymerase and 3.0 mmol
MgCl2. DNA was amplified for 45 cycles after initial acti-
vation of HotStart Taq DNA polymerase for 15 min. The
PCR products were separated by electrophoresis on 2%
agarose gel and identified by ethidium-bromide staining.
The gels were then placed under UV light for visualization
the amplified products. The primer sequences were: PVB1
5'-AGC ATG TGG AGT GAG GGG GC-3', PVB2 5'-AAA
GCA TCA GGA GCT ATA CTT CC-3'. Primers of PVB1 and
2 were used for the first round of reaction, resulting in
PCR amplicon of 290 bp; a 173 bp parvovirus B19-spe-
cific amplicon was obtained by the nested PCR primers
PVB3 and PVB4 (5'-GCT AAC TCT GTA ACT TGT AC-3, 5'-
AAA TAT CTC CAT GGG GTT GAG-3').
Following fixation, representative sections of the right and
left atria, and ventricles as well as the interventricular sep-
tum were obtained. Sections were dehydrated in serial
ethanol and xylene solutions and embedded in paraffin.
Six micron sections were obtained and stained withhema-
toxylin and eosin. Anti-Parvovirus antibody, is IgG mouse
monoclonal antibody was applied to deparaffinized sec-
tions following an incubation period. The tissue was then
counter stained with Hematoxylin. Finally, a bluing rea-
gent was then applied.
Pathological findings
An autopsy restricted to heart and lungs was performed.
On external examination the patient had generalized
icterus and anasarca. Internal examination revealed an
unremarkable larynx and correct anatomic position of the
thoracic organs. The right and left pleural cavities con-
tained approximately 500 ml of serous fluid each. The
right lung weighted 970 grams, the left 750 grams and
both were severely congested, exuding a copious amount
of blood and frothy fluid.
The heart weighed 460 grams, with 2 cm of aorta attached,
and the pericardium removed. There was 140 ml of serous
pericardial fluid. The coronary arteries arose normally,
and the right coronary artery was dominant. The coronary
ostia arose in the sinuses of Valsalva below the sinotubu-
lar junction. There was mild to moderate calcific athero-
sclerosis. The tricuspid valve and pulmonary valves were
unremarkable. The right ventricular outflow and pulmo-
nary valves were unremarkable. The mitral valve was with-
out evidence of prolapse or annular calcification, and the
papillary muscles were normal. The aortic valve was trile-
aflet and unremarkable. The endocardium had focal hem-
orrhages. The left ventricular wall measured 17 mm, theDiagnostic Pathology 2008, 3:21 http://www.diagnosticpathology.org/content/3/1/21
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ventricular septum 4 mm, and the right ventricle 6 mm.
There was no evidence of necrosis, fibrosis or infarcts. Tis-
sue was saved and frozen for molecular studies.
Microscopic sections of coronary arteries showed mild
atherosclerosis. Sections of the left and right ventricles
and ventricular septum showed no evidence of myocar-
dial ischemia. There was a diffuse interstitial myocardial
inflammatory infiltrate composed of CD68 positive mac-
rophages (figure 1C, 1D), CD3 (figure 1E) lymphocytes in
an interstitial and perivascular distribution with minimal
necrosis. The infiltrates were most prominent around cap-
illaries and arterioles (figure 1A, 1B). Immunohistochem-
ical stains for CD20 (figure 1F) and S-100 were negative.
Immunohistochemical stains for parvovirus B19 were
negative as well. However, parvovirus B19 DNA was
detected in cardiac muscle using non-quantitative PCR
analysis. Special stains for fungi on cardiac sections were
negative.
Microscopic sections of the bilateral lungs revealed diffuse
alveolar damage with interstitial inflammation, but with
out evidence of pneumonia or vasculitis. Immunohisto-
chemical stains for CMV and human herpes virus were
negative. A GMS stain for bacterial and fungal organisms
is also negative.
Discussion
Human parvovirus B19 infects human erythroid cells and
causes hemolytic anemia, fifth disease and hydrops feta-
lis. [12] Other less common manifestations of the disease
include acute and chronic rheumatoid-like arthropathy
[13], acute glomerulonephritis [14], pneumonia and
acute or chronic cardiac diseases, such as acute and
chronic myocarditis, perimyocarditis, biventricular
thrombi, heart failure, dilated cardiomyopathy, isolated
left ventricular dysfunction and death related to cardio-
genic shock [9,10,15-21]. Additionally PVB19 has been
associated with myocarditis in heart transplant
patients[22].
The mechanism of how parvovirus virus infects noneryth-
roid cells is unknown [23]. In the heart, it has been postu-
lated that PVB19 does not infect myocytes, but
endothelial cells of small intracardiac arterioles and
venules, resulting in impairment of myocardial microcir-
culation with secondary myocyte necrosis during acute
infection[24,25]. Alternatively, it has been proposed that
myocarditis arises from immunological cross-reaction to
epitopes shared between the virus and the myocardium
[11,19].
The rate of viral genome detection in endomyocardial
biopsies has been extensively explored. One study [26]
reported that one third of biopsies from patients sus-
pected to have myocarditis were positive for enteroviruses
and a second one reported about one fourth[27]. Adeno-
virus has also been reported on detected by PCR in cardiac
biopsies. Martin et al detected adenovirus DNA in 15 of
38 patients with clinical signs of myocarditis, and also
found a small proportion of cases positive for cytomega-
lovirus and herpesvirus[28]. More recently, Grumbach et
al reported enteroviruses in about 1/3 of patients with
myocarditis or dilated cardiomyopathy and interestingly,
did not find any case of adenovirus[29]. Calabrese found
about 35% of prevalence of entero and adenoviruses in
patients with myocarditis[30]. These studies did not
investigate the presence of parvovirus B19. A larger series
of 624 endomyocardial biopsies showed twice as much
adenovirus than enterovirus by PCR [31] and only about
1% of B19 positive cases.
The rate of parvovirus detection in endomyocardial biop-
sies is quite variable. Schowengerdt studied 41 patients
heart recipients to find a low (7%) rate of B19 genome[7].
In the last few years, additional studies showed a detec-
tion that ranged from 13 to 50% in different populations
[31-35]. The detection of parvovirus by molecular meth-
ods in heart tissue is considered quite specific for sympto-
matic infection. In a series of 215 cardiac biopsy controls,
Bowles et al did not find a single case positive for B19
genome[36].
The histologic appearance of parvoviral myocarditis has
been described in a few case studies in patients with sero-
logic or molecular confirmation of the diagnosis. There
have been several reports of parvoviral myocarditis in
children and immunocompromised adults. Heegaard et
al reported B19 myocarditis in an adult heart transplant
recipient [37]. Parvoviral infection was confirmed by IgM
serology and PCR detection in myocardial tissue of viral
genome. The histologic appearance was described as sim-
ilar to transplant rejection, but the sample was limited to
endomyocardial biopsy [38]. At least two autopsy cases
have been reported of fatal parvoviral myocarditis in chil-
dren. The interstitial and perivascular nature of the infil-
trate and the preponderance of macrophages was stressed
[11]. In one case, fatal myocarditis occurred two weeks
after erythema infectiosum (Fifth's disease)[19]. The his-
tologic features in limited cases are that of interstitial
inflammation, abundant macrophages in addition to
lymphocytes, rare B-cells, and patchy necrosis[19].
There have been subsequent reports of parvoviral myocar-
ditis in immunocompetent adult patients. Bultmann
described a fatal case of a 34 year-old woman with the
clinical presentation of ischemic heart disease. The diag-
nosis of parvoviral myocarditis was made at autopsy by
quantitative PCR which showed high copy numbers of
viral genome is myocardial tissue[10]. Histologically,Diagnostic Pathology 2008, 3:21 http://www.diagnosticpathology.org/content/3/1/21
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Histopathological findings in parvoviral myocarditis Figure 1
Histopathological findings in parvoviral myocarditis. 1A. Diffuse interstitial myocardial inflammatory infiltrate more 
prominent around interstitial capillaries and composed of macrophages and lymphocytes (20×). 1B. Hematoxilin-eosin stain 
showing vasocentric inflammation (40×). 1C-1D. CD68 positive macrophages were the most abundant cells present. (Figure 
1C-10X Figure 1D-20X) 1E. Rare CD3 positive lymphocytes. 1F. Essentially negative CD20 immunohistochemical stain.Diagnostic Pathology 2008, 3:21 http://www.diagnosticpathology.org/content/3/1/21
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there were foci of necrosis surrounded by macrophages
and T-lymphocytes, with dilatation of intramural small
veins and post-capillary venules, with a vasculitis-like pat-
tern of lymphocytic infiltration. Lamparter reported an
otherwise healthy 37 year-old man who also developed
symptoms of ischemic heart disease[9]. Left ventricular
biopsy shows an interstitial infiltrate of T-lymphocytes
and macrophages. Parvoviral genome was detected by
Southern blot and PCR analysis in myocardial tissue. In
adults, although the histologic features are variable, par-
voviral myocarditis usually consists of non-specific inter-
stitial perivascular mononuclear infiltrates, foci of
necrosis and macrophage infiltration.
Identification of viral protein has not been accomplished
in cases of parvoviral myocarditis by immunohistochem-
ical techniques. [11,19] Possibly, there is no infection of
the myocytes, and the mechanism of inflammation is
immune sensitivity by cross reacting. However, one report
has described detection of viral DNA in endothelial cells
in a case of fatal parvoviral myocarditis[10]. In this
reported case, in situ hybridization using radiolabeled
antisense probes demonstrated labeling in areas of
venules and arteries, suggesting infection of endothelial
cells.
In addition to being responsible for a significant propor-
tion of cases of lymphocytic myocarditis, enteroviruses
have also been implicated in the transition from myocar-
ditis to dilated cardiomyopathy (DCM)[35]. The role of
parvovirus in the development of idiopathic cardiomyop-
athy has been recently explored. In the study published by
Kuhl et al [35], 51% of the 245 patients with idiopathic
left ventricular dysfunction were positive for B19 DNA
against 9.4 and 1.6% of enterovirus and adenovirus
respectively.
In conclusion, parvovirus should be considered as etiol-
ogy in fatal myocarditis, even in adults, especially when
the infiltrate is mononuclear with macrophages and inter-
stitial predominance. Molecular techniques, specifically
PCR, can establish the diagnosis post-mortem. Pre-mor-
tem diagnosis should also be attempted, as treatment with
immunoglobulin has been suggested [37] and rapid diag-
nosis may be necessary.
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